Abbott Raises Quarterly Dividend for 54th Consecutive Year

<h2>Abbott Continues Dividend Growth Streak for 54th Year</h2> <p>Abbott Laboratories has announced a 6.8% increase in its quarterly common dividend, raising it to 63 cents per share. This move extends the healthcare company's record of consecutive annual dividend increases to 54 years, maintaining its status among the S&P 500's Dividend Aristocrats and the elite group of "Dividend Kings" with over 50 years of consistent hikes.</p> <p>The dividend growth reflects Abbott's diversified business model and its resilience, particularly in volatile market conditions. Since 2020, the company's dividend has grown more than 70%, and its payout dates back to 1924 with 408 consecutive quarterly dividends. The next payment is scheduled for February.</p> <p>Beyond shareholder returns, Abbott has reported significant progress in its business segments during 2025. Key developments include the planned acquisition of Exact Sciences, expected to add a new growth vertical in the rapidly expanding $60 billion U.S. cancer screening and precision oncology diagnostics markets. The company also secured CE Mark for its Volt™ Pulsed Field Ablation System for treating atrial fibrillation and received FDA approval for the Tendyne™ device, designed to replace the mitral valve without open-heart surgery.</p> <p>Abbott has also invested in expanding its global manufacturing and R&D capabilities, including new facilities in the United States. These strategic moves, combined with a century-long history of uninterrupted dividend payments and over five decades of increases, underscore the company's commitment to delivering long-term value for its shareholders.</p>